Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Charles River Labs Intl buy The Goldman Sachs Group, Inc.

Charles River Labs Intl
Start price
€159.40
23.01.25 / 50%
Target price
€182.70
23.01.26
Performance (%)
15.50%
End price
€184.10
24.01.26
Summary
This prediction ended on 24.01.26 with a price of €184.10. The prediction had a final performance of 15.50%. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Charles River Labs Intl -4.396% -4.396% 42.199%
iShares Core DAX® -1,74 % 5,67 % 7,84 %
iShares Nasdaq 100 2,81 % 11,55 % 36,61 %
iShares Nikkei 225® -0,11 % 9,65 % 45,65 %
iShares S&P 500 0,97 % 7,24 % 26,97 %

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Charles River Labs Intl diskutieren
Prediction Buy
Perf. (%) 15.50%
Target price 182.704
Change
Ends at 23.01.26

Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $220.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
23.01.25
In the thread Trading Charles River Labs Intl
Prediction Buy
Perf. (%) 15.50%
Target price 182.704
Change
Ends at 23.01.26

Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten

The Goldman Sachs Group, Inc. 
0
Report Share
24.01.26

Stopped prediction by The_Goldman_Sachs_Gr for Charles River Labs Intl

buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€199.65
06.06.24
€266.42
06.06.25
-36.41%
07.06.25

The Goldman Sachs Group, Inc. 
06.06.24 50%